COVID-19 and the Thyroid Function in Patients with HCV - Associated Hepatocellular Carcinoma
Author(s) -
Letiția Toma,
Anca Zgură,
Teodora Isac,
Razvan Simu,
Adriana Mercan-Stanciu,
Mihai Dodot,
Laura Iliescu
Publication year - 2022
Publication title -
acta endocrinologica (bucharest)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.249
H-Index - 13
eISSN - 1843-066X
pISSN - 1841-0987
DOI - 10.4183/aeb.2022.392
Subject(s) - medicine , thyroid , gastroenterology , hepatitis c virus , thyroglobulin , thyroid function , hepatocellular carcinoma , autoantibody , antibody , anti thyroid autoantibodies , immunology , virus
COVID-19 is more than a respiratory infection, with deep implications regarding multiple systems and organs. Thyroid damage is frequent in COVID-19 and may overlap previous HCV or HCC associated diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom